Pharmathene(PIP)

Pharmathene(PIP)2019-04-02 11:05

$Pharmathene(PIP)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-04-01 AccNo: 0001564590-19-010429 Size: 13 MB 网页链接查看全文

Pharmathene(PIP)2019-03-16 10:35

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-03-15 AccNo: 0001193125-19-076851 Size: 27 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial St...查看全文

Pharmathene(PIP)2019-03-12 00:05

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-03-11 AccNo: 0001193125-19-070141 Size: 596 KBItem 1.01: Entry into a Material Definitive AgreementItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Pharmathene(PIP)2019-03-12 00:05

$Pharmathene(PIP)$ 424B2 - Prospectus [Rule 424(b)(2)] Filed: 2019-03-11 AccNo: 0001193125-19-070146 Size: 517 KB 网页链接查看全文

Pharmathene(PIP)2019-03-09 00:50

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-03-08 AccNo: 0001193125-19-067835 Size: 64 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Pharmathene(PIP)2019-02-15 12:00

$Pharmathene(PIP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-14 AccNo: 0001104659-19-008563 Size: 88 KB 网页链接查看全文

Pharmathene(PIP)2019-02-09 10:50

$Pharmathene(PIP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-08 AccNo: 0001213900-19-001904 Size: 68 KB 网页链接查看全文

Pharmathene(PIP)2019-02-12 10:30

$Pharmathene(PIP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-11 AccNo: 0001193125-19-033928 Size: 71 KB 网页链接查看全文

Pharmathene(PIP)2019-02-02 12:20

$Pharmathene(PIP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-01 AccNo: 0001393825-19-000035 Size: 60 KB 网页链接查看全文

Pharmathene(PIP)2019-02-06 10:15

$Pharmathene(PIP)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2019-02-05 AccNo: 0001104659-19-005825 Size: 106 KB 网页链接查看全文

Pharmathene(PIP)2019-10-02 04:50

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-10-01 AccNo: 0001193125-19-259847 Size: 38 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission o...查看全文

Pharmathene(PIP)2019-08-23 14:35

$Pharmathene(PIP)$ DEF 14A - Other definitive proxy statements Filed: 2019-08-22 AccNo: 0001193125-19-226618 Size: 964 KB 网页链接查看全文

Pharmathene(PIP)2019-08-22 15:10

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-08-21 AccNo: 0001193125-19-225595 Size: 34 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Pharmathene(PIP)2019-08-21 03:40

$Pharmathene(PIP)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2019-08-19 AccNo: 0001193125-19-224357 Size: 965 KB 网页链接查看全文

Pharmathene(PIP)2019-08-17 09:55

$Pharmathene(PIP)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-08-14 AccNo: 0001193125-19-221188 Size: 52 KB 网页链接查看全文

Pharmathene(PIP)2019-08-15 01:05

$Pharmathene(PIP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-13 AccNo: 0001564590-19-031795 Size: 5 MB 网页链接查看全文

Pharmathene(PIP)2019-08-15 01:05

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-08-13 AccNo: 0001564590-19-031811 Size: 395 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Pharmathene(PIP)2019-08-11 03:00

$Pharmathene(PIP)$ PRE 14A - Other preliminary proxy statements Filed: 2019-08-09 AccNo: 0001193125-19-218069 Size: 921 KB 网页链接查看全文

Pharmathene(PIP)2019-07-16 02:45

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-07-15 AccNo: 0001193125-19-193586 Size: 39 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements a...查看全文

Pharmathene(PIP)2019-07-10 02:30

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-07-09 AccNo: 0001193125-19-190926 Size: 7 MBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibi...查看全文

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-10-01 AccNo: 0001193125-19-259847 Size: 38 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submission o...

$Pharmathene(PIP)$ DEF 14A - Other definitive proxy statements Filed: 2019-08-22 AccNo: 0001193125-19-226618 Size: 964 KB 网页链接

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-08-21 AccNo: 0001193125-19-225595 Size: 34 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$Pharmathene(PIP)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2019-08-19 AccNo: 0001193125-19-224357 Size: 965 KB 网页链接

$Pharmathene(PIP)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-08-14 AccNo: 0001193125-19-221188 Size: 52 KB 网页链接

$Pharmathene(PIP)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-13 AccNo: 0001564590-19-031795 Size: 5 MB 网页链接

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-08-13 AccNo: 0001564590-19-031811 Size: 395 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$Pharmathene(PIP)$ PRE 14A - Other preliminary proxy statements Filed: 2019-08-09 AccNo: 0001193125-19-218069 Size: 921 KB 网页链接

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-07-15 AccNo: 0001193125-19-193586 Size: 39 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements a...

$Pharmathene(PIP)$ 8-K - Current report Filed: 2019-07-09 AccNo: 0001193125-19-190926 Size: 7 MBItem 1.01: Entry into a Material Definitive AgreementItem 3.02: Unregistered Sales of Equity SecuritiesItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibi...